TQ Quiz | Common Quotes in Glaucoma Care Buy, Sell or Hold (Nashville 2025) by Events@optometricedu.com | Oct 22, 2025 | 2025 Nashville, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 90 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. In the study that reported that at least 25-35% of retinal ganglion cell loss is associated with abnormal visual fields the average glaucoma eye had what percentage loss?* A - 10% B - 30% C - 50% D - 70% 2. Studies show that the average RNFL average thicknesses on average that are more likely to have corresponding field loss are?* A - 63um Spectralis, 100um Cirrus B - 100um Spectralis, 63um Cirrus C - 75um Cirrus, 89um Spectralis D - 110um Spectralis, 107um Cirrus 3. Glaucoma is typically inaccurately depicted in patient information handouts as* A - A black tunnel with central sparing B - Having missing parts C - Having a central black scotoma D - A white tunnel 4. Gonioscopy is done what percentage of the time across most studies?* A - 20% B - 50% C - 80% D - 100% 5. Which of the following is true according to the Duke Glaucoma registry in patients that achieved an IOP under 15mmHg* A - 100% of them no longer progressed B - some of them paradoxically gained tissue thickness C - They were more likely to die than progress D - 9% of them continued to progress rapidly 6. Intraocular Pressure is* A - Static B - Diurnal in nature C - Dynamic D - the only factor influencing glaucomatous disease 7. Although it is often said that structure always precedes function* A - This is a false statement and the relationship is more nuanced B - This is an accurate statement and we should never treat until there is both functional and structural loss that corresponds C - This is false and we should always assume function proceeds structure D - This is accurate, especially when it come to using 10-2s 8. Which of the below is not a treatment fact* A - Most patients are NOT non-responders B - None of the major studies have specifically addressed what the ideal IOP lowering should be for individual patients or groups C - Adherence to targets has been shown to slow global progression D - Phase III Latanoprost trials showed 25% of patients had an IOP lowering effect of less then 10% 9. All of the following are progression pearls except for _____* A - Progression usually behaves in a linear fashion B - A target rate of progression is likely more important than a target IOP C - Risk of progression in the real world is much greater than in well controlled clinical trials D - 2 OCT scans per year are likely sufficient to detect progression 10. The phase III (20 year) OHTS results indicated that* A - Patients who developed bilateral glaucoma were unlikely to have a visual field defect B - Most patients never took their study provided medications C - On average the number of participants who died was approximately the same as the number of patients who developed POAG D - Ocular hypertension is not a risk factor for the development of POAG 11. Reasons that visual fields and OCT don’t always align include all of the following except ______* A - OCT is in linear units and visual fields are non-linear B - Tissue thickness is not an exact surrogate for retinal ganglion cell function C - Visual field testing exhibits perfect repeatability and low variability D - Current use of the 24-2 visual field may under sample damaged RGCs 12. According to Quigley’s work, what is unique about glaucoma that is not unique to other optic neuropathies?* A - Disc pallor B - Loss of laminar tissue C - Arcuate visual field defects D - Loss of neural tissue 13. In updated EMGT studies structure and function progressed at the same rate in ___ out of 306 eyes* A - 1 B - 50 C - 100 D - 200 14. According to Hood et al. the OCT-driven definition of glaucoma involves these features* A - Superior quadrant RNFL thickening B - An OCT GCL defect that is overlaps or is consistent with the RNFL defect C - Glow scale thinning in the papillo-macular bundle D - presence of an epiretinal membrane 15. Corneal Hysteresis has been shown to be* A - A poor indicator of a patient’s risk of glaucomatous damage B - Equivalent to central corneal thickness C - More useful than Central Corneal thickness in predicting progression D - Useful in keratoconus patients 16. Goldmann tonometry’s success is based on all the following assumptions except* A - 520um thickness B - That applanation is reliable only on “normal” corneas C - That the cornea functions like a membrane that has no biomechanical properties other than thickness D - That home tonometry would ultimately replace it 17. Correcting applanation surface tonometry _____* A - aligns with goldman tonometry on “nominal” cornea B - Is minimally affected by CCT C - Has shown that patients previously labeled as non-responders were actually not D - All of the above 18. The GONE project, the 5 Rs and NERVE mnemonic all advocate for the use of______* A - a systematic approach to evaluating the optic nerve for glaucoma B - Looking only for a C/D ratio C - Ruling out nasal cupping D - Counting the number of laminar pores visible 19. Which of the following cannot be considered to be a glaucoma masquerader* A - NA-AION B - A-AION C - Myopic nerve head insertions D - CRVO 20. Which statement is correct about primary angle closure glaucoma diagnostics, prevalence and practice patterns in the United States and Canada?* A - Many patients labeled as open angle by referring ODs and MDs were found to have angle closure when assessed prior to cataract surgery at tertiary centers B - Studies show that most ODs and OMDs consistently do gonioscopy C - Anterior segment OCT is very dynamic and can detect synechiae better than gonioscopy can D - Gonioscopy on shallow angles with convex irises is a simple technique Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeNashville 2025 - Identifying and Managing Pharmaceutical Complications*After 90 days, pricing will increase to $30. Price: Retake Discount Price: Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
